bioAffinity Technologies, Inc. Shares Outstanding (Cover Page)
bioAffinity Technologies, Inc. (BIAF) had Shares Outstanding (Cover Page) of 8.10 million shares as of 2026-08-03, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-07
- 2026-08-03: Entity Common Stock, Shares Outstanding 8.10M shares.
- 2026-05-04: Entity Common Stock, Shares Outstanding 4.53M shares.
- 2026-03-13: Entity Common Stock, Shares Outstanding 4.50M shares.
- 2025-11-11: Entity Common Stock, Shares Outstanding 4.50M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 8.10M shares 10-Q · filed 2026-08-07 |
| 2026-05-04 | 4.53M shares 10-Q · filed 2026-05-11 |
| 2026-03-13 | 4.50M shares 10-K · filed 2026-03-16 |
| 2025-11-11 | 4.50M shares 10-Q · filed 2025-11-14 |
| 2025-08-13 | 28.47M shares 10-Q · filed 2025-08-14 |
| 2025-05-13 | 27.25M shares 10-Q · filed 2025-05-15 |
| 2025-03-31 | 18.26M shares 10-K/A · filed 2025-04-29 |
| 2024-11-12 | 15.58M shares 10-Q · filed 2024-11-14 |
| 2024-08-12 | 13.45M shares 10-Q · filed 2024-08-14 |
| 2024-05-08 | 11.66M shares 10-Q · filed 2024-05-15 |
| 2024-03-20 | 11.51M shares 10-K · filed 2024-04-01 |
| 2023-11-08 | 9.50M shares 10-Q · filed 2023-11-14 |
| 2023-08-14 | 8.78M shares 10-Q · filed 2023-08-14 |
| 2023-05-12 | 8.52M shares 10-Q · filed 2023-05-15 |
| 2023-03-20 | 8.46M shares 10-K · filed 2023-03-31 |
| 2022-11-10 | 8.37M shares 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |